Tim Muilwijk

760 total citations
29 papers, 234 citations indexed

About

Tim Muilwijk is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Tim Muilwijk has authored 29 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Urology. Recurrent topics in Tim Muilwijk's work include Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (14 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Tim Muilwijk is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Urinary and Genital Oncology Studies (14 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Tim Muilwijk collaborates with scholars based in Belgium, Türkiye and Italy. Tim Muilwijk's co-authors include Steven Joniau, Murat Akand, Frank Van der Aa, Hendrik Van Poppel, Maarten Albersen, Lisa Moris, Daimantas Milonas, Mindaugas Jievaltas, Wouter Everaerts and Thomas Gevaert and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Urology.

In The Last Decade

Tim Muilwijk

26 papers receiving 233 citations

Peers

Countries citing papers authored by Tim Muilwijk

Since Specialization

Citations

This map shows the geographic impact of Tim Muilwijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Muilwijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Muilwijk more than expected).

Fields of papers citing papers by Tim Muilwijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Muilwijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Muilwijk. The network helps show where Tim Muilwijk may publish in the future.

Co-authorship network of co-authors of Tim Muilwijk

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Muilwijk. A scholar is included among the top collaborators of Tim Muilwijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Muilwijk. Tim Muilwijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression 2024 ·European Urology Open Science ·Tim Muilwijk, (unknown), Murat Akand, Sofie Daelemans, Koen M. Marien, (unknown), Pieter‐Jan van Dam, Mark Kockx, Thomas Van den Broeck, Ben Van Cleynenbreugel, Frank Van der Aa, Thomas Gevaert, Steven Joniau	3
2	Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non–muscle-invasive bladder cancer using multi-layered –omics studies 2024 ·Frontiers in Oncology ·Murat Akand, Tatjana Jatsenko, Tim Muilwijk, (unknown), Steven Joniau, Frank Van der Aa	0
3	Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial 2023 ·European Urology Open Science ·(unknown), Christien Caris, Marc‐Oliver Grimm, Marc Colombel, Tim Muilwijk, Luis Martínez‐Piñeiro, Marko Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders Bjartell, Wim P.J. Witjes, Antoine G. van der Heijden, Lambertus A. Kiemeney	3
4	Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry 2022 ·European Urology Oncology ·Tim Muilwijk, Murat Akand, (unknown), (unknown), Kathy Vander Eeckt, Siska Van Bruwaene, Ben Van Cleynenbreugel, Steven Joniau, Frank Van der Aa	2
5	Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer 2021 ·Journal of Cellular and Molecular Medicine ·Tim Muilwijk, Murat Akand, Frank Van der Aa, Vincent De Coninck, (unknown), (unknown), Markus Eckstein, (unknown), Louis Libbrecht, Steven Joniau, Thomas Gevaert	9
6	Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer 2021 ·PLoS ONE ·Tim Muilwijk, Murat Akand, Sofie Daelemans, Koen M. Marien, Yannick Waumans, Mark Kockx, (unknown), Thomas Van den Broeck, Frank Van der Aa, Thomas Gevaert, Steven Joniau	9
7	Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold 2021 ·Journal of Clinical Medicine ·(unknown), Tim Muilwijk, (unknown), Mindaugas Jievaltas, Steven Joniau, Daimantas Milonas	9
8	Benefits and harms of the new prostate cancer grade grouping on the prediction of long‐term oncological outcomes in patients after radical prostatectomy 2021 ·International Journal of Urology ·Daimantas Milonas, Tim Muilwijk, (unknown), Gaëtan Devos, Steven Joniau	1
9	The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer‐specific survival after radical cystectomy: external validation in a large bi‐institutional cohort 2020 ·British Journal of Urology ·Tim Muilwijk, Murat Akand, Francesco Soria, Andrea Giordano, Uroš Milenković, Lisa Moris, Thomas Gevaert, Hendrik Van Poppel, Maarten Albersen, Paolo Gontero, Steven Joniau	8
10	Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma 2020 ·World Journal of Urology ·Benjamin Pradère, David D‘Andrea, Victor M. Schuettfort, Beat Foerster, Fahad Quhal, Keiichiro Mori, Mohammad Abufaraj, Vitaly Margulis, (unknown), Alberto Briganti, Tim Muilwijk, Kees Hendricksen, Yair Lotan, (unknown), Shahrokh F. Shariat	6
11	Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS). 2020 ·Journal of Clinical Oncology ·Marc‐Oliver Grimm, (unknown), Marc Colombel, Luis Martínez‐Piñeiro, Tim Muilwijk, Marek Babjuk, Levent N. Türkeri, (unknown), Anup Patel, Anders Bjartell, Christien Caris, Raymond G. Schipper, Wim P.J. Witjes	4
12	The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients 2020 ·PLoS ONE ·Thomas Gevaert, Yves‐Rémi Van Eycke, Thomas Van den Broeck, Hendrik Van Poppel, Isabelle Salmon, Sandrine Rorive, Tim Muilwijk, Frank Claessens, Dirk De Ridder, Steven Joniau, Christine Decaestecker	9
13	Comparison of postoperative complications of ileal conduits versus orthotopic neobladders 2020 ·Translational Andrology and Urology ·(unknown), Maarten Albersen, Tim Muilwijk, Uroš Milenković, Lisa Moris, Wouter Everaerts, Hendrik Van Poppel, Frank Van der Aa, Steven Joniau, Murat Akand	16
14	Metastasectomy of oligometastatic urothelial cancer: a single-center experience 2020 ·Translational Andrology and Urology ·Tim Muilwijk, Murat Akand, Frank Van der Aa, Herlinde Dumez, Gert De Meerleer, Dirk Van Raemdonck, Paul De Leyn, Hendrik Van Poppel, Maarten Albersen, Steven Joniau	12
15	Prognostic score predicts overall survival following complete urinary tract extirpation 2020 ·Scandinavian Journal of Urology ·Murat Akand, Tim Muilwijk, Frank Van der Aa, Thomas Gevaert, Uroš Milenković, Lisa Moris, (unknown), Hendrik Van Poppel, Maarten Albersen, Steven Joniau	2
16	Patient‐reported outcomes after buccal mucosal graft urethroplasty for bulbar urethral strictures: results of a prospective single‐centre cohort study 2020 ·British Journal of Urology ·(unknown), Tim Muilwijk, Kathy Vander Eeckt, Frank Van der Aa, Steven Joniau	8
17	Quality Control Indicators for Transurethral Resection of Non–Muscle-Invasive Bladder Cancer 2019 ·Clinical Genitourinary Cancer ·Murat Akand, Tim Muilwijk, (unknown), (unknown), Steven Joniau, Frank Van der Aa	35
18	Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System 2019 ·Frontiers in Oncology ·Murat Akand, Tim Muilwijk, Jan J. Cornelissen, Siska Van Bruwaene, Kathy Vander Eeckt, (unknown), P. Mattelaer, (unknown), Ben Van Cleynenbreugel, Steven Joniau, Frank Van der Aa	3
19	Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer 2019 ·Frontiers in Oncology ·Gaëtan Devos, Tim Muilwijk, (unknown), (unknown), Lisa Moris, Thomas Van den Broeck, Charlien Berghen, Gert De Meerleer, Maarten Albersen, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau	9
20	Localized prostate cancer and robot-assisted laparoscopic radical prostatectomy: a retrospective, comparative study between pre- and post-operative Gleason scores 2017 ·Acta chirurgica Belgica ·(unknown), (unknown), Tim Muilwijk, Thomas H. Adams, H. Vandeursen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact